Well, you don’t have a choice, so here’s the Good News! When we went to Houston last week for my 8th treatment of the new immunotherapy trial drug, my doctors offered us to move to a different clinical trial (still at MD Anderson). This trial is among the latest effort of Targeted Therapies uniquely targeting genetic mutations. The treatment uses Small Molecular Inhibitors (SMI) to target a gene pathway that regulates the survival of cells. Mesothelioma has a deregulating, or abnormal pathway. This new medicine is a blocker, like a switch, that tells the cells to stop growing and even shrink. We are very excited to enter this new treatment. If you refer back to the graph I posted in the previous two blogs, you’ll see this procedure is listed in the “Experimental Treatment” column of cutting edge efforts to control Mesothelioma. And, here’s some of the reasons we are so optimistic: Unlike Chemotherapy and Immunotherapy, which are both transfusions, this trial is an oral drug. O
Beating the Odds is about my upcoming battle to defeat Peritoneal Mesothelioma with multiple objectives. I have a large network of friends and family supporting me along with the prayer teams at churches I’ve never attended. I hope this method of sharing information will be easier for all of us. My plan is to come through this battle whole. If my success story helps anyone else on their journey with this disease it will make this effort priceless.